These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 15202167

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH).
    Sasaki N, Ueno T, Morita Y, Nagata E, Sata M.
    Hepatogastroenterology; 2006; 53(71):678-81. PubMed ID: 17086867
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transient abnormal myelopoiesis associated with Down syndrome presenting as severe hydrops fetalis: a case report.
    Malin GL, Kilby MD, Velangi M.
    Fetal Diagn Ther; 2010; 27(3):171-3. PubMed ID: 20160425
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
    Trocme C, Leroy V, Sturm N, Hilleret MN, Bottari S, Morel F, Zarski JP.
    J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
    [Abstract] [Full Text] [Related]

  • 9. [Transitory abnormal myelopoiesis of the monoblastic form in a newborn infant with Down's syndrome and liver cirrhosis].
    Urano Y, Kondo M, Hayashi Y, Wakuya J, Nakata T, Tanaka K, Seo A.
    Ann Pathol; 1983 Dec; 3(4):337-9. PubMed ID: 6230084
    [Abstract] [Full Text] [Related]

  • 10. Transient abnormal myelopoiesis (TAM) causing multiple organ failure.
    Hoskote A, Chessells J, Pierce C.
    Intensive Care Med; 2002 Jun; 28(6):758-62. PubMed ID: 12107683
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.
    Pereira TN, Lewindon PJ, Smith JL, Murphy TL, Lincoln DJ, Shepherd RW, Ramm GA.
    J Hepatol; 2004 Oct; 41(4):576-83. PubMed ID: 15464237
    [Abstract] [Full Text] [Related]

  • 16. Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome.
    Dormann S, Krüger M, Hentschel R, Rasenack R, Strahm B, Kontny U, Niemeyer C.
    Eur J Pediatr; 2004 Jul; 163(7):374-7. PubMed ID: 15138809
    [Abstract] [Full Text] [Related]

  • 17. [Serum markers of liver fibrosis].
    Schuppan D, Jax C, Hahn EG.
    Dtsch Med Wochenschr; 1999 Oct 15; 124(41):1213-8. PubMed ID: 10572522
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transient abnormal myelopoeisis in newborns with Down syndrome.
    Zarina AL, Hamidah A, Yong SC, Rohana J, Hamidah NH, Azma RZ, Boo NY, Jamal R.
    Malays J Pathol; 2007 Dec 15; 29(2):107-11. PubMed ID: 19108403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.